Biotech Investors Jolted Out of Summer Lull as High-Fliers Sink

Login to Listen
(Bloomberg) -- Investors are having an eventful day in drug-developer stocks after regulatory and manufacturing issues rocked a trio of high-flying companies on Wall Street.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.